iTonic Holdings Ltd. (ITOC)

Market Cap	5.27M -90.8%
Revenue (ttm)	523,031 +16.7%
Net Income	-5.10M
EPS	-0.32
Shares Out	17.05M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	133,862
Open	0.3180
Previous Close	0.3090
Day's Range	0.2986 - 0.3180
52-Week Range	0.2513 - 32.0000
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Mar 20, 2026

About ITOC

iTonic Holdings Ltd., a healthcare solutions provider, develops and commercializes treatment software and devices used for brachytherapy. Its proprietary treatment planning system is a radioactive particle implantation, a radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. The company offers FTTPS, a treatment planning system for treating various malignant tumors, which could determine the target volume, prescription dose, and dose limitation to protect organs...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Sep 5, 2024
• Employees: 10
• Stock Exchange: NASDAQ
• Ticker Symbol: ITOC
• Website: https://www.ftzy.com.cn

Financial Performance

In 2025, iTonic Holdings's revenue was $523,031, an increase of 16.70% compared to the previous year's $448,196. Losses were -$5.10 million, 671.7% more than in 2024.